Is Immix Biopharma, Inc. (IMMX) a Buy, Sell, or Hold?
NASDAQ : IMMX
Immix Biopharma, Inc. — Analyst Ratings
$8.32 USD
-$0.23 (-2.69%)
- Volume
- 1.59M
- Average Volume
- 1.76M
- Market Capitalization
- $452.62M
- P/E Ratio
- -9.04
- Dividend Yield
- 0.00%
- Price Target
- $17.00
- Year High
- $12.14
- Year Low
- $1.94
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.76
Analyst Consensus Summary
Consensus Rating
Sell
4 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-51.1%
vs Current Price
Price Target
$17.00
Average TargetPrice Target Range
Lowest Target
$14.00
-40.6% DOWNSIDE
Average Target
$17.00
Median Estimate
Highest Target
$20.00
-58.4% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 4
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 4 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Robert Burns | $20 | $8.915 | 2026-05-22 10:38 AM | 124.3% |
| Mizuho Securities | Graig Suvannavejh | $14 | $6.74 | 2026-02-09 05:35 AM | 107.7% |
| H.C. Wainwright | Robert Burns | $7 | $1.98 | 2024-07-01 02:08 AM | 253.5% |